Global Human cytomegalovirus 65 kDa Phosphoprotein Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human cytomegalovirus 65 kDa Phosphoprotein by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human cytomegalovirus 65 kDa Phosphoprotein by Country/Region, 2017, 2022 & 2028

2.2 Human cytomegalovirus 65 kDa Phosphoprotein Segment by Type

2.2.1 HB-101

2.2.2 CyMVectin

2.2.3 ASP-0113

2.2.4 PepVax

2.2.5 Others

2.3 Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type

2.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2017-2022)

2.3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Sale Price by Type (2017-2022)

2.4 Human cytomegalovirus 65 kDa Phosphoprotein Segment by Application

2.4.1 Brain Tumor

2.4.2 Hemotaological Tumor

2.4.3 Kidney Transplant Rejection

2.4.4 Liver Transplant Rejection

2.4.5 Others

2.5 Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application

2.5.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sale Market Share by Application (2017-2022)

2.5.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Sale Price by Application (2017-2022)

3 Global Human cytomegalovirus 65 kDa Phosphoprotein by Company

3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Breakdown Data by Company

3.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Annual Sales by Company (2020-2022)

3.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Company (2020-2022)

3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Annual Revenue by Company (2020-2022)

3.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Company (2020-2022)

3.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Company (2020-2022)

3.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Sale Price by Company

3.4 Key Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Product Location Distribution

3.4.2 Players Human cytomegalovirus 65 kDa Phosphoprotein Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human cytomegalovirus 65 kDa Phosphoprotein by Geographic Region

4.1 World Historic Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Geographic Region (2017-2022)

4.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Annual Revenue by Geographic Region

4.2 World Historic Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Country/Region (2017-2022)

4.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Annual Revenue by Country/Region

4.3 Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth

4.4 APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth

4.5 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth

4.6 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth

5 Americas

5.1 Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country

5.1.1 Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2022)

5.1.2 Americas Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2022)

5.2 Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type

5.3 Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region

6.1.1 APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region (2017-2022)

6.1.2 APAC Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region (2017-2022)

6.2 APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type

6.3 APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein by Country

7.1.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2022)

7.1.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2022)

7.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type

7.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein by Country

8.1.1 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2022)

8.2 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type

8.3 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human cytomegalovirus 65 kDa Phosphoprotein

10.3 Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein

10.4 Industry Chain Structure of Human cytomegalovirus 65 kDa Phosphoprotein

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human cytomegalovirus 65 kDa Phosphoprotein Distributors

11.3 Human cytomegalovirus 65 kDa Phosphoprotein Customer

12 World Forecast Review for Human cytomegalovirus 65 kDa Phosphoprotein by Geographic Region

12.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast by Region

12.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Forecast by Region (2023-2028)

12.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human cytomegalovirus 65 kDa Phosphoprotein Forecast by Type

12.7 Global Human cytomegalovirus 65 kDa Phosphoprotein Forecast by Application

13 Key Players Analysis

13.1 Astellas Pharma Inc

13.1.1 Astellas Pharma Inc Company Information

13.1.2 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

13.1.3 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Astellas Pharma Inc Main Business Overview

13.1.5 Astellas Pharma Inc Latest Developments

13.2 Hookipa Biotech AG

13.2.1 Hookipa Biotech AG Company Information

13.2.2 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

13.2.3 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Hookipa Biotech AG Main Business Overview

13.2.5 Hookipa Biotech AG Latest Developments

13.3 Immunomic Therapeutics Inc

13.3.1 Immunomic Therapeutics Inc Company Information

13.3.2 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

13.3.3 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Immunomic Therapeutics Inc Main Business Overview

13.3.5 Immunomic Therapeutics Inc Latest Developments

13.4 Vakzine Projekt Management GmbH

13.4.1 Vakzine Projekt Management GmbH Company Information

13.4.2 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

13.4.3 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Vakzine Projekt Management GmbH Main Business Overview

13.4.5 Vakzine Projekt Management GmbH Latest Developments

13.5 Vaximm AG

13.5.1 Vaximm AG Company Information

13.5.2 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

13.5.3 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Vaximm AG Main Business Overview

13.5.5 Vaximm AG Latest Developments

13.6 VBI Vaccines Inc

13.6.1 VBI Vaccines Inc Company Information

13.6.2 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

13.6.3 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 VBI Vaccines Inc Main Business Overview

13.6.5 VBI Vaccines Inc Latest Developments

13.7 Vical Inc

13.7.1 Vical Inc Company Information

13.7.2 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

13.7.3 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Vical Inc Main Business Overview

13.7.5 Vical Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Human cytomegalovirus 65 kDa Phosphoprotein Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human cytomegalovirus 65 kDa Phosphoprotein Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of HB-101

Table 4. Major Players of CyMVectin

Table 5. Major Players of ASP-0113

Table 6. Major Players of PepVax

Table 7. Major Players of Others

Table 8. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2017-2022)

Table 10. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2017-2022) & ($ million)

Table 11. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Type (2017-2022)

Table 12. Global Human cytomegalovirus 65 kDa Phosphoprotein Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2017-2022)

Table 15. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application (2017-2022)

Table 16. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Application (2017-2022)

Table 17. Global Human cytomegalovirus 65 kDa Phosphoprotein Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Company (2020-2022)

Table 20. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Company (2020-2022)

Table 22. Global Human cytomegalovirus 65 kDa Phosphoprotein Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Producing Area Distribution and Sales Area

Table 24. Players Human cytomegalovirus 65 kDa Phosphoprotein Products Offered

Table 25. Human cytomegalovirus 65 kDa Phosphoprotein Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share Geographic Region (2017-2022)

Table 30. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country/Region (2017-2022)

Table 34. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country (2017-2022)

Table 38. Americas Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country (2017-2022)

Table 40. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2017-2022)

Table 42. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2017-2022)

Table 44. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Region (2017-2022)

Table 46. APAC Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Region (2017-2022)

Table 48. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2017-2022)

Table 50. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2017-2022)

Table 52. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country (2017-2022)

Table 54. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country (2017-2022)

Table 56. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2017-2022)

Table 58. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Human cytomegalovirus 65 kDa Phosphoprotein

Table 69. Key Market Challenges & Risks of Human cytomegalovirus 65 kDa Phosphoprotein

Table 70. Key Industry Trends of Human cytomegalovirus 65 kDa Phosphoprotein

Table 71. Human cytomegalovirus 65 kDa Phosphoprotein Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Human cytomegalovirus 65 kDa Phosphoprotein Distributors List

Table 74. Human cytomegalovirus 65 kDa Phosphoprotein Customer List

Table 75. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Forecast by Region

Table 77. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share Forecast by Application (2023-2028)

Table 95. Astellas Pharma Inc Basic Information, Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base, Sales Area and Its Competitors

Table 96. Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

Table 97. Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Astellas Pharma Inc Main Business

Table 99. Astellas Pharma Inc Latest Developments

Table 100. Hookipa Biotech AG Basic Information, Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base, Sales Area and Its Competitors

Table 101. Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

Table 102. Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Hookipa Biotech AG Main Business

Table 104. Hookipa Biotech AG Latest Developments

Table 105. Immunomic Therapeutics Inc Basic Information, Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base, Sales Area and Its Competitors

Table 106. Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

Table 107. Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Immunomic Therapeutics Inc Main Business

Table 109. Immunomic Therapeutics Inc Latest Developments

Table 110. Vakzine Projekt Management GmbH Basic Information, Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base, Sales Area and Its Competitors

Table 111. Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

Table 112. Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Vakzine Projekt Management GmbH Main Business

Table 114. Vakzine Projekt Management GmbH Latest Developments

Table 115. Vaximm AG Basic Information, Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base, Sales Area and Its Competitors

Table 116. Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

Table 117. Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Vaximm AG Main Business

Table 119. Vaximm AG Latest Developments

Table 120. VBI Vaccines Inc Basic Information, Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base, Sales Area and Its Competitors

Table 121. VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

Table 122. VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. VBI Vaccines Inc Main Business

Table 124. VBI Vaccines Inc Latest Developments

Table 125. Vical Inc Basic Information, Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base, Sales Area and Its Competitors

Table 126. Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Offered

Table 127. Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Vical Inc Main Business

Table 129. Vical Inc Latest Developments

List of Figures

Figure 1. Picture of Human cytomegalovirus 65 kDa Phosphoprotein

Figure 2. Human cytomegalovirus 65 kDa Phosphoprotein Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of HB-101

Figure 10. Product Picture of CyMVectin

Figure 11. Product Picture of ASP-0113

Figure 12. Product Picture of PepVax

Figure 13. Product Picture of Others

Figure 14. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type in 2021

Figure 15. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Type (2017-2022)

Figure 16. Human cytomegalovirus 65 kDa Phosphoprotein Consumed in Brain Tumor

Figure 17. Global Human cytomegalovirus 65 kDa Phosphoprotein Market: Brain Tumor (2017-2022) & (K Pcs)

Figure 18. Human cytomegalovirus 65 kDa Phosphoprotein Consumed in Hemotaological Tumor

Figure 19. Global Human cytomegalovirus 65 kDa Phosphoprotein Market: Hemotaological Tumor (2017-2022) & (K Pcs)

Figure 20. Human cytomegalovirus 65 kDa Phosphoprotein Consumed in Kidney Transplant Rejection

Figure 21. Global Human cytomegalovirus 65 kDa Phosphoprotein Market: Kidney Transplant Rejection (2017-2022) & (K Pcs)

Figure 22. Human cytomegalovirus 65 kDa Phosphoprotein Consumed in Liver Transplant Rejection

Figure 23. Global Human cytomegalovirus 65 kDa Phosphoprotein Market: Liver Transplant Rejection (2017-2022) & (K Pcs)

Figure 24. Human cytomegalovirus 65 kDa Phosphoprotein Consumed in Others

Figure 25. Global Human cytomegalovirus 65 kDa Phosphoprotein Market: Others (2017-2022) & (K Pcs)

Figure 26. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2017-2022)

Figure 27. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Application in 2021

Figure 28. Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Company in 2021

Figure 30. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Geographic Region in 2021

Figure 32. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Region (2017-2022)

Figure 33. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country/Region in 2021

Figure 34. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales 2017-2022 (K Pcs)

Figure 35. Americas Human cytomegalovirus 65 kDa Phosphoprotein Revenue 2017-2022 ($ Millions)

Figure 36. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales 2017-2022 (K Pcs)

Figure 37. APAC Human cytomegalovirus 65 kDa Phosphoprotein Revenue 2017-2022 ($ Millions)

Figure 38. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales 2017-2022 (K Pcs)

Figure 39. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales 2017-2022 (K Pcs)

Figure 41. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue 2017-2022 ($ Millions)

Figure 42. Americas Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country in 2021

Figure 43. Americas Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country in 2021

Figure 44. United States Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Region in 2021

Figure 49. APAC Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Regions in 2021

Figure 50. China Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country in 2021

Figure 57. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country in 2021

Figure 58. Germany Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country in 2021

Figure 65. Egypt Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Human cytomegalovirus 65 kDa Phosphoprotein in 2021

Figure 71. Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein

Figure 72. Industry Chain Structure of Human cytomegalovirus 65 kDa Phosphoprotein

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles